1. Home
  2. Vol 27, No 6s (2023)
  3. Akpor

Knowledge, attitude, and utilization of human papillomavirus vaccination among female undergraduates in Ekiti State, Nigeria

Oluwaseyi A. Akpor(1), Adewale T. Adeyiolu(2), Modupe I. Alade(3), Senami Adebiyi(4), Richard S. Adeola(5), Benedict T. Adeyanju(6),


(1) Faculty of Nursing Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State
(2) Department of Obstetrics and Gynaecology, Afe Babalola University Multisystem Hospital, Ado-Ekiti, Ekiti State
(3) Faculty of Nursing Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State
(4) Faculty of Nursing Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State
(5) Faculty of Nursing Sciences, Afe Babalola University, Ado-Ekiti, Ekiti State
(6) Department of Obstetrics and Gynaecology, Afe Babalola University Multisystem Hospital, Ado-Ekiti, Ekiti State
Corresponding Author

Abstract


Despite the introduction of the Human Papillomavirus (HPV) vaccine in Nigeria in 2009, vaccination rate is still low and the disease-related mortality remains high. This study evaluated the knowledge, attitude, and utilization of HPV vaccinations among female undergraduates in a university in Ekiti State, southwest Nigeria. This was an observational study that utilized a standardized questionnaire to obtain information from 200 female participants who were selected using multistage sampling technique. The data was analyzed and presented with descriptive statistics, while Chi- square was used to test any significance in observed differences and relationships between variables. About 53.3% of the respondents had fair knowledge of HPV. Results on utilization were extremely low as only 5.4% had received the vaccination in all three doses. The major barriers to HPV utilization were inadequate awareness about the vaccine (53.0%), concern about its cost and safety (41.1% and 40.1% respectively). We conclude that HPV vaccination campaign should be extensively encouraged especially among university students. The cost of the vaccine should be subsidised to encourage its uptake, thereby reducing cervical cancer incidence and deaths in the country.

References


Centre for Disease Control and Prevention (CDC). Human Papillomavirus infection. Retrieved from https://www.cdc.gov/std/hpv/stdfact-hpv.htm. 2022.

Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiNubile MJ, Lindsay BR, Kuter BJ, Perez G, Dominiak-Felden G, Saah AJ, Drury R, Das R and Velicer C. Impact and effectiveness of the quadrivalent Human Papillomavirus vaccine. A systemic review of 10 years of Real-world experience. Journal of Clinical Infectious Diseases. 2016; 63(4):519-527.

Wang X, Song Y, Wei X, Wang G, Sun R, Wang M and Lijun Zhao. Prevalence and distribution of human Papillomavirus genotypes among women attending gynecology clinics in Northern Henan Province China. Virology Journal. 2022;19(6) https://doi.org/10.1186/s12985-021-01732-8.

Wang X, Huang X and Zhang Y. Involvement of human papillomaviruses in cervical cancer. Frontiers in Microbiology. 2018; 9:2896 https://doi.org/10.3389/fmicb.2018.02896.

Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR, Viswanathan AN and Gaffney DK. Cervical cancer: A global health crisis. Cancer. 2017:123(13):2404-2412.

World Health Organization. Cervical cancer. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cervical -cancer. 2022,

National Cancer Institute. HPV and Cancer. https://www.cancer.gov/about-caner/causes-prevention/risk/infectious-agents/hpv-fact-sheet.2015.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. International Journal of Cancer. 2010; 127:2893-917.

Agida T, Akaba G, Isah A and Ekele B. Knowledge and perception of Human Papillomavirus vaccine among the antenatal women in a Nigerian tertiary hospital. Nigerian Medical Journal. 2015;56(1) 23-27.

Louie KS, de Sanjose S and Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health. 2009:14(10):1287-302.

World Health Organization. WHO vaccine-preventable diseases: monitoring system global summary. Retrieved from http://apps.who.int/immunization. 2016.

Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX and de Sanjosé S. Human Papillomavirus and Related Diseases inNigeria. Summary Report 2015. ICO Information Centre on HPV and Cancer (HPV Information Centre).

Kabir A, Bukar M, Nggada HA, Rann HB, Gidado A and Musa AB. Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria. Pan Africa Medical Journal. 2019:33(284).

Umezulike A, Tabansi N, Ewunonu A and Nwanka, E. Epidemiological characteristics of carcinoma of the cervix in the Federal Capital Territory of Nigeria. Nigerian Journal of Clinical Practice. 2013;10(2): 143-146.

WHO. Comprehensive cervical cancer: a guide to essential practice. Geneva: WHO Press; 2014.

Ezenwa N, Balogun M and Okafor I. Mothers’ Human Papillomavirus Knowledge and willingness to vaccinate their adolescent daughters in Lagos Nigeria. International Journal of Women’s health. 2013;5(37)1-7.

Brown B and Folayan M. Barriers to uptake of Human Papillomavirus vaccine in Nigeria: A population in need. Nigerian Medical Journal. 2015;56(4)301.

Odetola TD and Ekpo K. Nigerian women’s perspective about Human Papillomavirus Immunizations. Journal of Community Medicine and Health Education. 2012;2(191).

Davis E. Young Adult Awareness and Knowledge of Human Papillomavirus, Oropharyngeal cancer and the HPV Vaccine. Retrieved from http://irlib.uwoca/etd/3384. 2015.

Isara AR and Osayi N. Knowledge of Human Papillomavirus and Uptake of its Vaccine among Female Undergraduate Students of Ambrose Alli University, Ekpoma, Nigeria. Journal of Community Medicine and Primary Health Care. 2021;33(1)64-75.

Oluwole EO, Idowu OM, Adejimi AA, Balogun MR and Osanyin GE. Knowledge, attitude and uptake of human papillomavirus vaccination among female undergraduates in Lagos State, Nigeria. J Family Med Prim Care. 2019;8(11):3627- 3633.

Ojimah C and Maduka O. Awareness and uptake of human papillomavirus vaccines among female undergraduate students: Implications for cervical cancer prevention in South-South, Nigeria. Port Harcourt Med J. 2017; 11:134-140.

Bisi-Onyemaechi AI, Ugo N. Chikani UN and Nduagubam O. Reducing incidence of cervical cancer: knowledge and attitudes of caregivers in a Nigerian city to human papillomavirus vaccination. Infectious Agents and Cancer. 2018; 13: 29.

Ifedioha CO and Azuike AC. Knowledge and attitudes about cervical cancer and its prevention among female secondary school students in Nigeria. Trop Med Int Health. 2018;23(7):714-723.

Azuogu B N, Umeokonkwo C D, Azuogu V C, Onwe O E, Okedo-Alex I N and Egbuji CC. Appraisal of willingness to vaccinate daughters with human papillomavirus vaccine and cervical cancer screening uptake among mothers of adolescent students in

Abakaliki, Nigeria. Niger J Clin Pract 2019;22: 1286-1291.

Omoseebi O, Okiki AP, Obajuluwa AO and Erinomo OO. Genotyping of Human Papilloma Virus (HPV) in Cervical Cancer at the Federal Teaching Hospital Ido-Ekiti, Ekiti State, Nigeria. Greener Journal of Medical Sciences. 2021;11(2): 201-211.

Solomon OO, Odu OO, Owoeye O, Solomon OA, Aduloju PO and Amu EO. Knowledge and acceptability of Human Papilloma Virus vaccine among women attending the obstetrics and gynecological clinics in a tertiary hospital Ado-Ekiti, Nigeria. Nigerian Journal of Family Practice. 2020;11(1): 1-8.

Akele RY, Amaechi CG, Oluboyo OB, Akinseye FJ, Enitan SS and Dada MO. Prevalence of Anti-Human Papillomavirus IgG Antibody among Students of a Private Tertiary Institution in Ado-Ekiti, Nigeria. Virology and Immunology Journal. 2020; 6(2):1-7.

Chandrasekaran AC. Assessing knowledge and attitudes of the Human Papillomavirus infection and vaccination among adolescence in Hartford CT. Connecticut: University of Connecticut 2015.

Hashemipour MA, Molouk TP, Modares Y and Zadefi SP. Knowledge of Medical and Dental Iranian Students about the Infection and Vaccination of Human Papilloma Virus. Pesqui. bras. odontopediatria clín. integr. 2019:19:191-49.

Alshehri AM, Alamri MMA, Alharazi AAM, Alhazmi AME, Alfaqih RMH, Alzaylaee AAI, Almarhabi SHA, Alfaqih HMA, Alderhami AAK, Mariam Harb Awadh Almarhabi MHA and Alsllami A. The awareness of the Human Papillomavirus Infection and Oropharyngeal Cancer in people to improve the Health Care System at A1 Qunfudhah Region, Kingdom of Saudi Arabia. Journal of Healthcare Engineering. 2021:2021;1-8.

Donadiki EM, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, Jimenez-Trujillo I and Velonakis EG. Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece. Hum Vaccin Immunother. 2013;9(2):300-5.

Albert B. Health promotion by social cognitive means. Health Education & Behaviour. 2004;31(2):143-64.

Sherris J, Agurto I, Arrossi S, Dzuba I, Gaffikin L, Herdman C, Limpaphayom K and Luciani S. Advocating for cervical cancer prevention. International Journal of Gynaecological Obstetrics 2005;89(2): S46–54.

Pandey D, Vanya V, Bhagat S and Shetty J. Awareness and Attitude towards Human Papillomavirus vaccine among medical students in premier medical school in India. Retrieved from https://doi.org/10.1371/journalprons.0040619. 2012.

Gottvall M. Knowledge and attitudes among youths, parents and staff in Sweden. Sweden: Uppsala University 2014.

Bailey HH, Chuang LT, duPont NC, Eng C, Foxhall LE, Merrill JK, Wollins DS and Blanke CD. American Society of Clinical Oncology Statement: HumanPapillomavirus Vaccination for Cancer Prevention. J Clin Oncol. 2016;20;34(15):1803-1892.

Nodulman JA, Randall S, Alberta SK, David BB and Cosette MW. Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs. 2015; 5:289-298.

Tsu VD, LaMontagne DS, Atahebwe P, Bloem PN and Ndiaye C. National implementation of HPV vaccination programs in low-resource countries: lessons, challenges and future prospects. Preventive Medicine. 2021;144.

Saunders KA. Factors that influence Human Papillomavirus vaccinations in young women residing in Canada. Canada: University of Windsor 2013.

Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, Ohi Y, Higashi M, Sagara Y, Yoshinaka H, Tsuji T, Natsugoe S, Douchi T, Eizuru Y and Akiba S. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008 Aug 5;99(3):408-14.

Akumbom AM, Lee JJ, Reynolds NR, Thayer W, Wang J and Slade E. Cost and effectiveness of HPV vaccine delivery strategies: A systematic review. Prev Med Rep. 2022;18; 26:101734.

Short MB, Rosenthal SL, Sturm L, Black L, Loza M, Breitkopf D and Zimet GD. Adult women's attitudes toward the HPV vaccine. J Women’s Health (Larchmt). 2010;19(7):1-7.

Burke CS. Getting vaccinated against HPV: attitudes, intentions and perceived barriers of female undergraduates. College Student Journal. 2010 Mar.;44(1).


Full Text: PDF

Article Metrics

Abstract View : 1801 times
PDF Download : 781 times

Refbacks

  • There are currently no refbacks.